Market News AIOpen the app

InspireMD finished selling shares and raised about $40.2 million.

New sharesRead the original at SEC EDGAR
Bad for NSPR

InspireMD raised cash, but sold additional shares and warrants that can turn into many more shares. The financing helps fund the company, yet those added ownership claims could leave current shareholders with smaller portions, so the ownership cost weighs more.

NSPR · InspireMD, Inc.

AI read · Bad for NSPR

The AI's read

The cash gives InspireMD more money to run its business. But the company issued shares, and the warrants allow many more shares to be bought later. That could leave current owners with much smaller portions of the company. The filing reports no new business results or specific use for the cash.

Get alerts for NSPR

Follow InspireMD, Inc. (NSPR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NSPR
Free on the App Store and Google Play, or on the web.